James Warren Huff is CEO at REATA PHARMACEUTICALS INC (RETA). They have made 4 open-market trades across 1 company since 2016, most recently 2023-09-26.
CIK 0001662411
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $1.3M since 2016, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RETA | 122,480 | $21.1M |
Shares reported on the most recent Form 4, priced at the 2023-07-10 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.